These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11055413)

  • 21. Effect of ursodeoxycholic acid on biochemical parameters, hepatocyte proliferation and liver histology in galactosamine hepatitis in the rat.
    Rudi J; Schlenker T; Raedsch R; Waldherr R; Zorn M; Stremmel W
    Res Exp Med (Berl); 1995; 195(5):309-15. PubMed ID: 8579639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xanthine oxidase-derived reactive oxygen species contribute to the development of D-galactosamine-induced liver injury in rats.
    Ohta Y; Matsura T; Kitagawa A; Tokunaga K; Yamada K
    Free Radic Res; 2007 Feb; 41(2):135-44. PubMed ID: 17364939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antihepatotoxic influence of silymarin on galactosamine hepatitis in the rat].
    Meyer-Burg J
    Klin Wochenschr; 1972 Nov; 50(22):1062-3. PubMed ID: 4637662
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of indigestible oligosaccharides on the hepatotoxic action of D-galactosamine in rats.
    Wang B; Egashira Y; Ohta T; Sanada H
    Biosci Biotechnol Biochem; 1998 Aug; 62(8):1504-9. PubMed ID: 9757556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of various kinds of dietary amino acids on the hepatotoxic action of D-galactosamine in rats.
    Wang B; Ishihara M; Egashira Y; Ohta T; Sanada H
    Biosci Biotechnol Biochem; 1999 Feb; 63(2):319-22. PubMed ID: 10192913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
    James GW; Pickering RW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An investigation and some parameters that affect the galactosamine model of hepatitis in the rat.
    Pickering RW; James GW; Parker FL
    Arzneimittelforschung; 1975 Jun; 25(6):898-901. PubMed ID: 1174326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatoprotective effect of germanium-containing Spirulina in rats with (D)-galactosamine- and lipopolysaccharide-induced hepatitis.
    Yoshinari O; Shiojima Y; Igarashi K
    Br J Nutr; 2014 Jan; 111(1):135-40. PubMed ID: 23768655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of lipopolysaccharide-induced liver injury by various types of tea and coffee in D-galactosamine-sensitized rats.
    He P; Noda Y; Sugiyama K
    Biosci Biotechnol Biochem; 2001 Mar; 65(3):670-3. PubMed ID: 11330687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1-methylmalate from camu-camu (Myrciaria dubia) suppressed D-galactosamine-induced liver injury in rats.
    Akachi T; Shiina Y; Kawaguchi T; Kawagishi H; Morita T; Sugiyama K
    Biosci Biotechnol Biochem; 2010; 74(3):573-8. PubMed ID: 20208347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against D-galactosamine-induced acute liver injury by oral administration of extracts from Lentinus edodes mycelia.
    Watanabe A; Kobayashi M; Hayashi S; Kodama D; Isoda K; Kondoh M; Kawase M; Tamesada M; Yagi K
    Biol Pharm Bull; 2006 Aug; 29(8):1651-4. PubMed ID: 16880621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant activity and hepatoprotective effect of a polysaccharide from Bei Chaihu (Bupleurum chinense DC).
    Zhao W; Li JJ; Yue SQ; Zhang LY; Dou KF
    Carbohydr Polym; 2012 Jun; 89(2):448-52. PubMed ID: 24750742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of propolis extract on D-galactosamine-induced hepatic injury in rats.
    Sugimoto Y; Tarumi T; Kaneko Y; Isayama S; Kawai N; Sugimoto H; Yamada H; Kamei C
    Biol Pharm Bull; 1999 Nov; 22(11):1237-9. PubMed ID: 10598035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression by Hydrangeae Dulcis Folium of D-galactosamine-induced liver injury in vitro and in vivo.
    Nakagiri R; Hashizume E; Kayahashi S; Sakai Y; Kamiya T
    Biosci Biotechnol Biochem; 2003 Dec; 67(12):2641-3. PubMed ID: 14730144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary wheat gluten alleviates the elevation of serum transaminase activities in D-galactosamine-injected rats.
    Manabe A; Cheng CC; Egashira Y; Ohta T; Sanada H
    J Nutr Sci Vitaminol (Tokyo); 1996 Apr; 42(2):121-32. PubMed ID: 8780970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of drug-induced hepatotoxicity by plasma retinol binding protein.
    Isozaki M; Masubuchi Y; Horie T
    In Vivo; 2002; 16(1):61-5. PubMed ID: 11980363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice.
    Huang H; Zhang X; Li J
    J Surg Res; 2015 May; 195(2):522-8. PubMed ID: 25818981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galactosamine-induced acute liver injury in rats reduces hepatic alpha-tocopherol transfer protein production.
    Takenaka A; Kita A; Ikeya M; Arai H; Igarashi K
    J Nutr Sci Vitaminol (Tokyo); 2007 Aug; 53(4):366-71. PubMed ID: 17934244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatoprotective effects of whey protein on D-galactosamine-induced hepatitis and liver fibrosis in rats.
    Kume H; Okazaki K; Sasaki H
    Biosci Biotechnol Biochem; 2006 May; 70(5):1281-5. PubMed ID: 16717438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of the hepatotoxicity of D-galactosamine in the rat by cycloheximide.
    Koff RS; Connelly LJ
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):519-22. PubMed ID: 1257252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.